您的位置: 首页 > 农业专利 > 详情页

MICROARN MODIFIÉS PAR 5-HALOGÉNO-URACILE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
专利权人:
The Research Foundation for The State University of New York
发明人:
JU, Jingfang
申请号:
EP17867742
公开号:
EP3534912A4
申请日:
2017.10.30
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present disclosure provides nucleic acid compositions that incorporate one or more halouracil molecules. More specifically, the present disclosure reveals that the replacement of uracil nucleotides within a microRNA nucleotide sequence with a 5-halouracil increases the ability of the micro-RNA to inhibit cancer progression and tumorigenesis. As such, the present disclosure provides various nucleic acid (e.g., microRNA) compositions having 5-halouracil molecules incorporated in their nucleic acid sequences and methods for using the same. The present disclosure further provides pharmaceutical compositions comprising the modified nucleic acid compositions, and methods for treating cancers using the same.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充